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Abstract
A key feature of many age-related diseases is the oxidative stress-induced accumulation of protein methionine sulfoxide
(PMSO) which causes lost protein function and cell death. Proteins whose functions are lost upon PMSO formation can be
repaired by the enzyme methionine sulfoxide reductase A (MsrA) which is a key regulator of longevity. One disease
intimately associated with PMSO formation and loss of MsrA activity is age-related human cataract. PMSO levels increase in
the eye lens upon aging and in age-related human cataract as much as 70% of total lens protein is converted to PMSO. MsrA
is required for lens cell maintenance, defense against oxidative stress damage, mitochondrial function and prevention of
lens cataract formation. Essential for MsrA action in the lens and other tissues is the availability of a reducing system
sufficient to catalytically regenerate active MsrA. To date, the lens reducing system(s) required for MsrA activity has not been
defined. Here, we provide evidence that a novel thioredoxin-like protein called thioredoxin-like 6 (TXNL6) can serve as a
reducing system for MsrA repair of the essential lens chaperone a-crystallin/sHSP and mitochondrial cytochrome c. We also
show that TXNL6 is induced at high levels in human lens epithelial cells exposed to H2O2-induced oxidative stress.
Collectively, these data suggest a critical role for TXNL6 in MsrA repair of essential lens proteins under oxidative stress
conditions and that TXNL6 is important for MsrA defense protection against cataract. They also suggest that MsrA uses
multiple reducing systems for its repair activity that may augment its function under different cellular conditions.
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Introduction
Significant evidence points to a major role for protein oxidations
in the etiology of many age-related human degenerative disorders
including Alzheimer’s disease [1–2], Parkinson’s disease [3–5], and
age-related cataract of the eye lens [6]. Protein oxidation can
result in altered conformation, activity, sub-cellular localization
patterns, and aggregation states which are associated with loss of
cellular functions, apoptosis, and cell death [7]. Proteins become
oxidized upon exposure to reactive oxygen species (ROS).
Exogenous sources of ROS include environmental oxidants,
radiation and drugs [8]. Endogenous ROS can arise as a by-
product of mitochondrial respiration through inefficient electron
coupling at complexes I and III of the electron transport chain [9–
10]. ROS levels increase upon aging as a consequence of multiple
events including age-related accumulation of mitochondrial
mutations, resulting from exposure to endogenous ROS [11].
The two most common protein oxidations upon aging and disease
are oxidation of cysteines and methionines [7][12][13].
Protein methionines (mets) are rapidly oxidized to form
protein methionine sulfoxides (PMSO) upon exposure to
hydrogen peroxide, hydroxyl radical, and other sources of
ROS [13]. In the eye lens, PMSO levels increase upon aging
[14] and in human cataractous lenses 60%–70% of total lens
protein is found as PMSO [15]. Age-related cataract, also called
mature onset cataract, is an opacity of the eye lens that occurs
relatively late in life, arising as a consequence of light scatter.
Oxidation of lens proteins is a key event in cataractogenesis
associated with loss of protein function, lens protein aggregation,
protein proteolysis, and ultimately cataract formation [8][16–
17]. Age-related cataract is an extremely prevalent disease that is
the leading cause of world blindness and the leading cost of
Medicare surgery in the US [18]. At present, surgery is the only
treatment for age-related cataract.
Unlike the majority of lens protein oxidations that are
irreversible, PMSO formation is repairable by a unique family
of enzymes called the methionine sulfoxide reductases (Msrs).
Oxidation of methionine generates a 50:50 mixture of S- and R-
forms of PMSO as a consequence of sulfur oxidation [19]. The
Msr family consists of a single enzyme, called MsrA, which
specifically repairs the S-form of PMSO and three separate
enzymes, called MsrB1, MsrB2 and MsrB3, which collectively
recognize the R-form of PMSO. Thus, statistically, 50% of PMSO
is repaired by MsrA while the remainder is repaired by one or
more MsrBs. MsrA and the MsrBs have been shown to provide
oxidative stress resistance to mammalian cells including eye lens
cells [20–23]. Of the Msrs, MsrA is the best characterized. MsrA
has been reported to extend lifespan by up to 70% through its
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15421over-expression in Drosophila melanogaster [24], while deletion of
MsrA in mice was reported to decrease maximum lifespan by
about 40% compared to wild type mice [25].
MsrA has been shown to play an important role in protection of
lens cells against oxidative damage and it has been shown to be
required for the maintenance of lens transparency in vivo [20–
21][26–27]. Gene silencing of MsrA decreases the resistance of lens
epithelial cells to H2O2-induced oxidative stress resulting in
increased mitochondrial ROS levels in human lens cells [20] and
loss of lens cell mitochondrial function [21]. Deletion of the MsrA
gene in mice leads to oxidative stress-induced cataract [26]. By
contrast, over-expression of MsrA in human lens cells protects
against oxidative stress and preserves mitochondrial function [20].
Recently,both cytochrome c (cytc) [26] and a-crystallin/sHSP [27]
have been identified as key targets of MsrA function in the lens.
Both proteins are critical for lens function. Cyt c is essential for
mitochondrial electron transfer and is a key initiator of apoptosis in
mammalian cells [28]. a-crystallin/sHSP is a molecular chaperone
that is essential for the maintenance of lens transparency whose
deletion has been shown to result in cataract formation [29–33]. a-
crystallin/sHSP is composed of two polypeptide subunits called aA-
and aB-crystallin [30]. Analysis of MsrA knockout mouse lenses
revealed oxidation of aB-crystallin/sHSP at methionine 68 [27].
Oxidation of a-crystallin/sHSP in vitro resulted in the specific
oxidation of aA at methionine 138 and the specific oxidation of aB-
crystallin at methionine 68 [27]. These oxidations resulted in a 50%
loss of chaperone activity. Treatment of methionine oxidized a-
crystallin/sHSP with MsrA in the presence of dithiothreitol (DTT)
resulted in complete repair of the oxidized methionines and the
restoration of a-crystallin/sHSP chaperone activity [27]. Further
analysis of the MsrA knockout mouse lenses revealed oxidation of
cyt c at met 80 [26]. In vitro analysis of met 80 oxidized cyt c showed
loss of cyt c oxidase activity and gain of cyt c peroxidase activity
[26]. Treatment of cyt c oxidized at met 80 with MsrA in the
presence of DTT resulted in repair of oxidized met 80, restoration
ofcyt coxidaseactivity,and decreasedcyt cperoxidase activity[26].
In all of these studies DTT was used as an MsrA reducing system
since the actual lens reducing system is not known. Since MsrA
knockout mice exposed to hyperbaric oxygen develop late-onset
cataract in association with methionine oxidation of essential lens
proteins, understanding the reducing requirements for MsrA action
on these proteins in the lens is an essential step towards
understanding the etiology of human cataract and the potential
development of therapies to prevent cataract development and
possibly other oxidative stress associated diseases.
MsrA repair of PMSO proceeds in three steps. First,
nucleophilic attack by the catalytic cysteine (Cys 51) on the target
PMSO releases 1 mol of protein methionine per mol of enzyme
and results in the transient formation of a sulfenic acid
intermediate within the MsrA molecule. The recycling cysteine
(Cys 198) then attacks the sulfenic acid intermediate forming an
intramonomeric disulfide bond with the concomitant release of
1 mol H2O. A key step in this reaction is reduction of the
intramonomeric disulfide bond making the action of MsrA
dependent on the availability of a reducing system to catalytically
reactivate the enzyme [34]. In E.coli and Saccharomyces cerevisiae
MsrA was shown to be able to use thioredoxin (Trx) as its reducing
system [35–36]. More recently, it has been shown that thionein
could also serve as a reducing system for E.coli MsrA and human
MsrB3 [37], suggesting that multiple reducing components can be
utilized for MsrA activity. Given the important role for MsrA in
lens function and the maintenance of key lens proteins, we sought
to identify additional lens reducing systems for the MsrA function.
One novel protein that could serve as a reducing agent for MsrA
repair activity is thioredoxin-like 6 protein (TXNL6), which is
called rod derived cone viability factor (RdCVF) in mice. TXNL6
has recently been discovered to confer viability to retinal cones
[38] and its deletion shown to decrease resistance to oxidative
stress in retinal cells of mice [39]. TXNL6 shares the catalytic
CXXC domain of Trx as well as the characteristic thioredoxin
fold [39]. Based on the recent report suggesting that thionein in
addition to Trx could serve to activate MsrA activity, we
hypothesized that TXNL6 might act as a reducing system for
MsrA repair of the essential lens proteins a-crystallin/sHSP and
cyt c. We also hypothesized that altered levels of TXNL6 upon
oxidative stress exposure of lens cells could augment the ability of
MsrA to repair essential lens proteins under oxidative conditions
and regulate MsrA activity through competition between different
reducing systems.
Our results indicate that in addition to the retina [38], TXNL6
is expressed in the human eye lens and multiple other human
tissues, that TXNL6 co-localizes with MsrA in the cytosol and the
mitochondria of lens cells, that TXNL6 expression is inducible in
lens cells upon oxidative stress exposure, and most importantly,
that TXNL6 acts as a novel reducing system for MsrA repair of cyt
c and a-crystallin/sHSP. These findings provide evidence that
TXNL6 is critical for the action of MsrA under oxidative stress
conditions and that TXNL6 is likely to play an important role in
cataract formation through its activation of MsrA.
Methods
Lens cell culture
A human lens epithelial cell line (HLE-B3) immortalized by
infection with adenovirus 12-SV40 [40] was grown and cultured in
DMEM (Invitrogen, Carlsbad, CA) supplemented with 15% FBS
(Invitrogen), gentamicin (50 units/ml; Invitrogen), penicillin-
streptomycin antibiotic mix (50 units/ml; Invitrogen) and
fungizone (5 ul/ml; Invitrogen) at 37uC in the presence of 5%
CO2.
Isolation of cytosolic and mitochondrial proteins
HLE-B3 cells (harvested at approximately passage 15) were
washed once in PBS before freezing at 280uC to weaken the cell
membrane. Pellets were frozen and thawed prior to re-suspension
in Clami buffer (250 mM sucrose, 1 mM EDTA, 70 mM KCl in
PBS) and lysed by Dounce homogenization. Lysates were
centrifuged at 700 g for 10 min at 4uC, the supernatant was
collected and centrifuged at 10,000 g for 15 min at 4uC. The
resulting supernatant contained the cytosolic protein. The pellet
containing the mitochondria was resuspended in 100 mlo f
universal buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl,
2 mM EDTA, 2 mM EGTA, 0.2% Triton X-100, 0.3% NP-40),
and incubated on ice for 30 min. The mixture was centrifuged at
20,000 g for 30 min at 4uC. The supernatant containing the
mitochondrial protein was stored at 220uC until used. Protein
concentrations were determined by Bradford protein assay as
previously described [20].
Analysis of TXNL6, Trx 1 and Trx 2 transcripts in human
tissues
TXNL6, Trx 1, Trx 2 and GAPDH transcripts were evaluated by
semi-quantitative RT-PCR using the SuperScriptH III one-step RT-
PCR system with Platinum Taq polymerase(Invitrogen) according to
the manufacturer’s instructions. 200 ng of total RNA was assayed
from indicated human tissues. RNA was isolated from microdissected
human lens epithelium and fiber cells as previously described [41].
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harvested. The average age of clear lenses obtained from the West
Virginia Eye Bank was 63 years of age. All lenses were obtained
within 24 h post mortem. RNA from other tissues was purchased
from BD Biosciences (Franklin Lakes, NJ). GAPDH was amplified as
the internal control transcript for 30 PCR cycles with a 60uC
annealing temperature using forward primer – CCACCCATGG-
CAAATTCCATGGCA and reverse primer - TCTAGACGG-
CAGGTCAGGTCCACC. TXNL6 transcripts were amplified for
35 PCR cycles with a 59uC annealing temperature and the primer
sequences: Forward primer – GCCGCATCCTGATCCGCAA-
CAATA and reverse primer – CACTGAGAACTGGCGCCC-
GAGGTC. Trx 1 and Trx 2 transcripts were amplified for 35 cycles
with annealing temperatures of 55uC and primer sequences Trx 1 –
forward primer – CCTTTCTTTCATTCCCTCTCTGA and
reverse primer – GCAACATCCTGACAGTCATCCA, Trx 2 -
forward primer – CTGGTGGCCTGACTGTAACAC and reverse
primer – GTTGACCACTCGGTCTTGAAA.
Localization of TXNL6 to the mitochondria in human lens
cells
HLE-B3 lens cells were plated onto coverslips and incubated
overnight in complete media. Double immunofluoresence-simul-
taneous staining was conducted by fixing cells with 3.7%
formaldehyde in PBS, blocking with 1% BSA and permeabilizing
with 0.25% Triton X-100 in PBS. For co-localization of TXNL6,
Trx 1 and Trx 2 to the mitochondria, first HLE cells were stained
with Mitotracker Red CMXRos (Molecular Probes, Invitrogen)
for 45 min at 250 nM as indicated by the manufacturer’s protocol.
Following mitotracker red staining, rabbit polyclonal anti-TXNL6
(ProteinTech Group Inc, Chicago, IL) at 1:1000 or rabbit
polyclonal anti-Trx 1 at 1:1500 (Abcam, Cambridge, MA), or
primary anti-Trx 2 (ProteinTech Group Inc) at 1:1000 were
incubated overnight in 4uC. Cells were washed three times with
PBS, and subsequently incubated with Alexa Fluor 488 goat anti-
rabbit secondary (Invitrogen) for 1 h at room temperature at
1:1000 dilutions. HLE cells were washed with three times with
PBS, and mounted onto slides. Immunofluoresence staining was
visualized with a Zeiss LSM 700 Confocal microscope.
Preparation, purification of and activation of TXNL6
TXNL6 protein was expressed from the Origene (Rockville,
MD) Homo sapiens TXNL6 (nucleoredoxin-like 1, NXNL1 gene)
vector which contains the TXNL6 cDNA under the control of the
T7 promoter. TXNL6 protein was produced from the TXNL6
vector using the T7 promoter-based Quick TNT coupled
transcription/translation system according to the instructions
and conditions specified by the manufacturer (Promega, Madison,
WI). Crude protein preparations were subsequently purified by gel
filtration on a Superdex
TM 200 10/300 column. The resulting
TXNL6 protein was examined by SDS-PAGE and western blot
analysis using the ProteinTech rabbit polyclonal TXNL6-specific
antibody for purity and identity. TXNL6 protein was activated by
reduction using a 5 molar excess of DTT (Sigma) and incubating
for 30 min at room temperature in Tris-HCl pH 7.4. DTT was
removed by ultrafiltration using an Amicon stirred ultrafiltration
cell with a 1000 kDa nominal molecular weight limit (NMWL)
membrane.
Analysis of TXNL6 transcript and protein in human lens
cells under oxidative stress conditions
HLE-B3 cells were plated in 6 well plates at a density of 4610
5
cells per well. Cells were incubated in serum free medium for 2 h
and then exposed to 200 mMH 2O2 (or PBS as a control) for 2 h in
serum free medium as previously described [42]. Cells were
washed once in PBS and returned to serum-supplemented
medium (15% serum) for recovery. Cells were harvested at the
times indicated and processed for RNA and protein. For protein
isolation, cells were washed with ice cold PBS and directly lysed on
the plate in lysis buffer (50 mM Tris-HCl ph 7.4, 150 mM NaCl,
1 mM EDTA, 1% NP40, 0.25% sodium deoxycholate) containing
1:1000 protease inhibitor cocktail (Sigma-Aldrich, St Louis, MO).
The lysates were sonicated for 10 sec62 and centrifuged at
10,000 g for 10 min; the supernatant contained the total cell
extract and was stored at 220uC until used. For RNA isolation
TrizolH reagent (Invitrogen) was used. Briefly, cells were washed in
1 ml of ice cold PBS, 1 ml of TrizolH reagent was added to the
plate and cells harvested using a cell scrapper. Phase separation
was performed by adding 0.2 ml of chloroform, vortexing for
15 sec and incubating at room temperature for 3 min. The
mixture was then centrifuged at 12,000 g for 15 min at 4uC. The
supernatant was removed into a fresh tube and precipitation of
RNA was achieved by adding 0.5 ml of isopropyl alcohol and
incubating at room temperature for 10 min. The precipitate was
centrifuged at 12,000 g for 10 min at 4uC and the resulting RNA
pellet washed twice in 75% alcohol. The washed pellet was air
dried and resuspended in RNAase/DNAase free water. RNA was
stored at 220uC until used. TXNL6, Trx1, Trx 2 and GAPDH
transcript levels were analyzed by semi-quantitative RT-PCR as
described above. TXNL6 protein levels were analyzed by western
blot analysis as described below.
SDS-PAGE and western blotting
SDS-PAGE and western blotting were carried out as previously
described [26], western blots were developed using ECL
TM
chemiluminescence reagents (GElifesciences, Buckinghamshire,
UK). Protein samples were mixed with 2x sample buffer at a 1:1
volume ratio and heated at 100uC for 5 min. Samples were
separated by electrophoresis on either 15% SDS-PAGE gels
(microdissected lens fractions, whole lens proteins, and HLE-B3
protein extracts) or 16% Tricine-SDS-PAGE gels for CNBr
cleaved proteins at room temperature for 1.5 h at 120 volts.
Tricine-SDS-PAGE gels were used for more complete separation
of low molecular weight CNBr products of cyt c and a-crystallin.
For Tricine-SDS-PAGE gel electrophoresis the method of
Schagger, 2006 [43] was used.
The following antibody concentrations were used where
appropriate: primary anti-TXNL6 (ProteinTech) 1:1000, primary
anti-Trx 1 at 1:1000 (Abcam), primary anti-Trx 2 (ProteinTech)
1:1000, primary anti-MsrA (Abcam) 1:2000, and secondary anti-
rabbit 1:5000. Gels were also stained with Colloidal blue for 4 h
and de-stained overnight in ddH2O.
Cytochrome c peroxidase assay
Cyt c (horse heart, Sigma-Aldrich) was treated with hypochlor-
ous acid (HOCl, Sigma-Aldrich) and subsequently MsrA/TXNL6
as follows: cyt c was incubated with HOCl in a 4:1 ratio for 15 min
at room temperature. After incubation, the excess HOCl was
removed from the oxidized cyt c using ultrafiltration on an
Amicon cell. Oxidized cyt c (291 mM) was incubated with MsrA
(1.9 mM) for 2 h at 37uC in the presence of TXNL6 (1.39 mM)
with rat liver thioredoxin reductase (TxrR)(2.4 mg, Sigma-Aldrich)
and NADPH (500 mM, Sigma-Aldrich). Repair of oxidized cyt c
was also carried out using human Trx 1 (1.39 mM, Sigma-Aldrich)
with TxrR/NADPH or yeast Trx 2 (1.39 mM, Abcam) with the
same reducing system. As controls oxidized cyt c was incubated
with MsrA with no reducing system, MsrA and TXNL6 in the
TXNL6 Activation of MsrA Repair
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no MsrA. The enzymatic peroxidase activity was measured by
2,29-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)diammonium
salt (ABTS) oxidation. The effect of oxidation on the peroxidatic
activity of cyt c was assayed by adding 0.6 mM cyt c to 1 ml of the
mixture containing 1.3 mM ABTS, 12 mM H2O2, and 100 mM
diethylenetriaminepentaacetic acid in 100 mM phosphate buffer
(pH 7.4) at 20uC, followed by measuring the increase in
absorbance at 420 nm [44]. Results from the cytochrome c
peroxidase assay are expressed as means 6 standard deviation
(SD). Differences among treatments of oxidized cyt c were
determined using Tukey’s test following one-way ANOVA.
p,0.05 was considered statistically significant.
Analysis of methionine oxidized and MsrA-repaired a-
crystallin and cytochrome c
Oxidation of a-crystallin/sHSP and cyt c and MsrA repair of
oxidized mets in these proteins was analyzed as previously
described [26–27] except that TxrR/NADPH and either TXNL6,
Trx1 or Trx 2 were used instead of DTT as the reducing system
for MsrA. Cyanogen bromide (CNBr) hydrolyzes peptide bonds at
the C-terminus of met residues; it does not cleave mets converted
to PMSO and is therefore a sensitive detection method to identify
met sulfoxide in proteins [45]. For a-crystallin/sHSP, bovine total
a-crystallin (1.0 mg, Sigma-Aldrich) was incubated with HOCl
(909 mM; molar ratio 100:1) at room temperature for 15 min to
convert mets to met sulfoxide as previously described [27]. Excess
HOCl was removed from the oxidized a-crystallin using
ultrafiltration on an Amicon cell. Oxidized mets in a-crystallin/
sHSP were repaired by incubating oxidized a-crystallin/sHSP
(6.36 mM) with MsrA (100 nM) using either DTT (15 mM) or
TXNL6 (10 mg; final concentration 2 mM and 20 mg; final
concentration 4.17 mM) with TxrR/NADPH as the reducing
system for the MsrA enzyme. Horse heart cyt c protein (Sigma-
Aldrich) (0.2 mM) was incubated with HOCl at a 4:1 (0.8 mM)
molar ratio at room temperature for 15 min. For repair of
oxidized mets, oxidized cyt c (291 mM) was incubated with 1.9 mM
MsrA for 2 h at 37uC using either DTT (15 mM) or TXNL6
(10 mg; final concentration 1.39 mM) with TxrR/NADPH as the
reducing system for the MsrA enzyme. Purified mouse MsrA was
obtained as a gift from Dr. Rodney Levine (NIH).
Samples were dried on a vacuum centrifuge and then treated or
not treated by CNBr cleavage. Treated or untreated a-crystallin/
sHSP or cyt c was then diluted in 70% formic acid to 10–20 mg/
ml as required by the standard CNBr protocol [45]. CNBr (Sigma-
Aldrich) was added in a 2:1 w/w ratio and the reaction mixture
incubated at room temperature for 20 h in the dark. The reaction
was terminated by addition of 5 volumes ddH2O and 5 volumes
1 M ammonium bicarbonate. Samples were then concentrated
using an Amicon stirred ultrafiltration cell. 5 mg of treated or
untreated a-crystallin/sHSP protein or cyt c was run on a 16%
Tricine-SDS-PAGE gel at 90 mV. The gels were fixed in 40%
methanol, 10% acetic acid for 2 h and stained overnight in
Coomassie blue stain. Gels were de-stained in 50% methanol,
10% acetic acid.
Results
TXNL6 is expressed in the eye lens and other human
tissues
Previous work in mice suggested that expression of TXNL6
(known as RdCVF in mice) is retina-specific; however, expression
in the lens or other ocular tissues was not reported [38]. Here,
TXNL6 levels were examined in two separate lens cell sub-types
called the lens epithelium and the lens fibers. The lens epithelium
covers the anterior surface of the organ, and the lens fiber cells lie
directly beneath the lens epithelium [46]. The lens epithelial cells
contain intact organelles and the majority of transporters and
metabolic enzymes in the lens [47–48], while the fiber cells are for
the most part devoid of organelles and contain the majority of
structural crystallin proteins required for light refraction and lens
transparency [49]. The lens is a unique organ since the cells and
proteins contained in the lens fibers must remain functional for the
life of the individual [46]. Protein aggregation in the lens fibers as a
result of oxidation, protein modifications, and/or proteolysis
results in loss of lens transparency and cataract formation [7][50].
Thus, expression of TXNL6 in the lens epithelium could suggest a
mitochondrial, transport or other epithelial specific function for
TXNL6, while expression in the lens fibers could suggest a
protective and/or repair function for TXNL6 in the maintenance
of lens crystallins or other lens fiber proteins.
To examine the possible expression of TXNL6 in lens epithelial
and lens fibers, whole human lenses (average age of clear lenses
obtained was 63 years of age) were microdissected into epithelium
and cortical fiber cells and RNA and protein prepared. TXNL6
transcripts were monitored by RT-PCR and TXNL6 protein
examined by western analysis using a TXNL6-specific antibody.
Trx 1 and Trx 2 transcripts were also examined as indicated for
comparison since these proteins are known to be expressed in the
lens [51] and could also function as a reducing system for lens
MsrA.
TXNL6 transcript was detected at significant levels in lens fiber
cells with lower levels detected in the lens epithelium (Figure 1
Panel A). Similarly, Trx 1 was ubiquitously expressed in the lens
(Figure 1 Panel B), while Trx 2 expression was mainly localized to
the lens epithelium as expected based on its known mitochondrial
expression pattern (Figure 1, Panel C). As a control for RNA
integrity and for loading, GAPDH was expressed equally in all
tissues (Figure 1 Panel D). TXNL6 (Figure 1 Panel A), Trx 1
(Figure 1 Panel B) and Trx 2 (Figure 1, Panel C) transcripts were
also detected in human retina, stomach, kidney, heart, colon, and
spleen. Interestingly, the levels of TXNL6 transcript appeared
Figure 1. TXNL6 transcript is detected in the human lens
epithelium and lens fiber cells and in other human tissues.
Ethidium bromide stained agarose gels show Panel A - TXNL6, Panel B -
Trx 1, Panel C - Trx 2 and Panel D GAPDH (control) transcript from
200 ng of RNA obtained from human tissues - 1. Lens epithelium, 2.
Lens Fiber, 3. Retina, 4. Stomach, 5. Kidney, 6.Heart, 7. Colon, and 8.
Spleen.
doi:10.1371/journal.pone.0015421.g001
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patterns for TXNL6 protein expression were identified for lens
epithelial and fibers by western blot analysis (Figure 2). These
results demonstrated that TXNL6 is expressed in the lens
epithelium, lens fiber cells and other human tissues. They also
indicated that TXNL6 could have a significant function in both
lens epithelial and fiber cells.
TXNL6 is detected in the cytosol and the mitochondria of
lens cells
MsrA has been localized to the cytosol and mitochondria of rat
[52] and mouse cells [53]. To determine if TXNL6 might co-
localize with MsrA in lens cells, we compared the sub-cellular
localization pattern of TXNL6 in lens cells first by western blotting
of lens cytosolic and mitochondrial protein fractions and second by
immunofluoresence staining. We also examined the sub-cellular
localization pattern of Trx 1 and Trx 2 as controls, since Trx 2 is
known to exhibit a mitochondrial specific expression pattern [54]
and Trx 1 is know to be mainly cytosolic however movements
within the cellular compartments are known [54][55].
Western blot analysis of cytosolic and mitochondrial protein
extracts from HLE-B3 cultured lens epithelial cells suggested that
both TXNL6 and MsrA are located in both the cytosol and the
mitochondria of lens cells (Figure 3, Panel A and B).
As controls, Trx 1 was located in both the cytosol and
mitochondria (Figure 3, Panel C) of the lens cells, while Trx 2 was
localized to the mitochondria as expected (Figure 3, Panel D)
demonstrating minimal contamination of the mitochondrial
extracts with cytosolic components. A secondary examination of
TXNL6 expression in HLE cells was conducted in vivo by
immunofluoresence staining (Figure 4, Panel A), TXNL6 was
co-localized with the mitochondrial-specific marker Mitotracker
Red along with Trx 1 and Trx 2 as controls. Consistent with the
western blot analysis, TXNL6 (green) co-localized with mito-
tracker (red) in the cultured HLE-B3 human lens epithelial cells
(Figure 4, Panel A - orange). Previous immunofluoresence staining
of the HLE-B3 cells with an MsrA-specific antibody [26] revealed
an identical expression pattern for MsrA in these cells. As controls,
immunofluoresence staining indicated that Trx 1 is located in both
the cytosol and mitochondria of these cells (Figure 4, Panel B)
while Trx 2 is located specifically in the mitochondria of these cells
as expected (Figure 4, Panel C) and in agreement with the western
blot analysis. These data provide strong evidence that TXNL6 co-
localizes with MsrA [26] in both the cytoplasm and mitochondria
of lens epithelial cells.
Oxidative stress induces TXNL6 mRNA and protein in
HLE-B3 cells
Significant evidence suggests that oxidative stress exposure and
accumulation of oxidized lens components upon aging is a major
factor in cataract development [8][16][56][17] and likely accounts
for increased PMSO formation associated with lens aging and
cataract. Since MsrA protects lens cells against oxidative stress, we
hypothesized that any reducing system needed for MsrA activity
might be activated by oxidative stress and thereby augment the
activity of MsrA to defend lens cells under these conditions. To
examine the levels of TXNL6 under oxidative stress conditions,
HLE-B3 lens epithelial cells were treated with 200 mMH 2O2 for
2 hours as previously established for optimal expression of
oxidative stress-specific lens transcripts [42] and the levels of
TXNL6 were examined at the RNA and protein level (Figure 5).
H2O2-treatment led to an increase in TXNL6 transcript levels
over the 16 h post-treatment time interval (Figure 5, Panel A).
Corresponding TXNL6 protein levels were also analyzed by
western analysis using a TXNL6-specific antibody. TXNL6
protein levels significantly increased over a 24 h period following
treatment (Figure 5, Panel B). Coomassie staining of the SDS-
PAGE gel indicates equal loading of total cellular protein
(Figure 5). As a control, no increase in TXNL6 expression was
seen in untreated HLE-B3 cells maintained identically (data not
shown). These data demonstrate that TXNL6 is induced in lens
epithelial cells upon oxidative stress exposure and suggest that
TXNL6 expression is a direct response of lens cells to oxidation.
TXNL6 can serve as reducing system for MsrA repair of
oxidized a-crystallin/sHSP and cytochrome c
MsrAhaspreviouslybeenshowntoberequiredfortherepairand
preservation of the function of the essential lens proteins cyt c [26]
and a-crystallin/sHSP [27] which regulate lens epithelial cell
apoptosis [28][33] and the maintenance of lens crystallin structure
[32]. These previous studies used HOCl as an oxidant since it
preferentially targets met residues in proteins [57]. Treatment of cyt
Figure 2. TXNL6 protein is present in human lens epithelium
and fiber cells. SDS-PAGE and immunoblotting of microdissected lens
epithelium (Epi) and lens fiber cell total protein extracts (20 mg) with a
TXNL6-specific antibody.
doi:10.1371/journal.pone.0015421.g002
Figure 3. TXNL6 is present in protein extracts prepared from
the cytoplasm and mitochondria of human lens epithelial cells.
SDS-PAGE and immunoblotting of Panel A - TXNL6, Panel B - MsrA,
Panel C - Trx 1, and Panel D -Trx 2 in 5 mg of protein extracts from the
cytoplasm and mitochondria of HLE-B3 lens epithelial cells using
specific antibodies.
doi:10.1371/journal.pone.0015421.g003
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sulfoxide which results in loss of cyt c function [26]. a-crystallin/
sHSP consists of two protein subunits called aA- and aB-crystallin
[30]. Treatment of a-crystallin/sHSP with HOCl results in the
specific oxidation of met 138 in aA- and met 68 of aB-crystallin/
sHSP [27]. To date, only DTT has been used as a reducing system
for MsrA repair of cyt c and a-crystallin/sHSP in vitro [26–27]. To
determine if TXNL6 could act as a reducing agent for MsrA, we
prepared cyt c specifically oxidized at met 80 [26] and a-crystallin/
sHSP specifically oxidized at met 138 of aA-crystallin and met 68 of
aB-crystallin[27] and determinedthe abilityofMsrAtorepairthese
using TXNL6 as a reducing system for MsrA activity.
A key characteristic of met 80 oxidized cyt c is conversion of cyt c
into an active peroxidase involved in the initiation of apoptosis
[26][58–60].Thus,cytcperoxidaseactivityisasensitiveassayforcyt
c met 80oxidation.As a first step inexamining the abilityof TXNL6
toact asa reducing system for MsrArepair ofcyt c,weexamined the
relative peroxidase activities of untreated (met 80 reduced), met 80
oxidized and met 80 oxidized cyt c that was repaired by MsrA using
TXNL6 with TxrR/NADPH as a reducing system (Figure 6) and
Trx 1 or Trx 2 with TxrR/NADPH as the reducing system
(Figure 6). As controls, met 80 oxidized cyt c was incubated with
MsrA with no reducing system, with MsrA and TXNL6 in the
absence of TxrR/NADPHand finallyTXNL6 with TxrR/NADPH
in the absence of MsrA. As expected, met 80 oxidation of cyt c
resulted in a statistically significant increase (p,0.001) in peroxidase
activity compared to the untreated protein (Figure 6). The
peroxidase activity of met 80 oxidized cyt c is labeled as 100%
peroxidase activity in these studies and all activities are relative to
met 80 oxidized cyt c. Untreated cyt c has only 15% peroxidase
activitybycomparison(Figure6).Treatmentofmet80oxidizedcytc
with MsrA using TXNL6 and TxrR/NADPH as a reducing system
significantly (p,0.001) decreased cyt c peroxidase activity by
approximately 50% suggesting that TXNL6 was able to serve as a
reducing system for MsrA repair of met 80 oxidized cyt c (Figure 6).
In addition, repair of met 80 oxidized cyt c using either Trx 1 or Trx
2 and TxrR/NADPH as the reducing systems also resulted in a
significant (p,0.001) approximate 50% reduction in peroxidase
activity for both reducing systems. As a control, repair using MsrA in
the absence of a reducing system resulted in only a 9% reduction in
peroxidase activity. Interestingly, repair of met 80 oxidized cyt c
using MsrA and TXNL6 in the absence of TxrR/NADPH results in
only a 14% decrease in peroxidase activity indicating that TXNL6
must be reduced by TxrR in order to activate the MsrA enzyme and
that TXNL6 can use TxrR/NADPH as its reducing enzyme. In the
absence of MsrA, incubation of met 80 oxidized cyt c with TXNL6
and TxrR/NADPH resulted in a 19% decrease in peroxidase
activity, demonstrating that cyt c met 80 repair is dependent on a
functional MsrA.
To further demonstrate that TXNL6 can serve as a reducing
system for MsrA repair of cyt c, untreated cyt c and met oxidized
cyt c and met oxidized a-crystallin/sHSP were treated with MsrA
and TXNL6 with TxrR/NADPH and the samples analyzed by
Tricine-SDS-PAGE following CNBr cleavage (Figures 7 and 8).
MsrA with DTT as the reducing system was examined as a
control. Cleavage of un-oxidized cyt c with CNBr should result in
Figure 4. Mitochondrial and cytosolic localization of TXNL6 in human lens epithelial cells. Co-localization of Panel A - TXNL6 (green),
Panel B - Trx 1 (green) and Panel C - Trx 2 (green), mitotracker red – a specific mitochondrial marker and merging of the two images (orange/yellow)
in HLE-B3 lens epithelial cells by immunofluoresence microscopy.
doi:10.1371/journal.pone.0015421.g004
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1.8 kDa. If both mets in cyt c are oxidized, no CNBr products
should be visualized. CNBr cleavage at met 80 should result in a
2.9 kDa band. CNBr cleavage of cyt c with oxidation at met 80 in
the absence of oxidation at met 65 should result in 7.2 kDa and
4.5 kDa peptides; while oxidation of met 65 in the absence of
oxidation at met 80 would yield 8.9 kDa and 2.9 kDa peptides.
As expected, CNBr cleavage of untreated cyt c resulted in the
visualization of a 7.1 kDa peptide on the coomassie stained
Tricine-SDS-PAGE gel as well as a lightly stained parent peptide
at 12 kDa (Figure 7, Lane 1). The 1.8 kDa peptide was not visible
in this gel. Oxidation of cyt c with a 4:1 molar ratio of HOCl
resulted in the loss of the 7.1 kDa peptide and an increase in the
12 kDa intact cyt c peptide (Figure 7, Lane 2). Incubation of the
met oxidized cyt c with MsrA and TXNL6 repaired the oxidized
mets in cyt c as evidenced by a significant increase in the staining
intensity of the 7.1 and 2.9 kDa bands, and a decreased staining
intensity of the intact cyt c 12 kDa peptide (Figure 7, Lane 4)
compared to the oxidized cyt c (compare Figure 7 Lanes 2 and 4).
As a control, oxidized cyt c was also repaired by MsrA using DTT
as a reducing agent (Figure 7, Lane 3) [26]. The repair of cyt c by
MsrA with TXNL6 (TxrR/NADPH) as a reducing system was not
100% efficient since a 50:50 ratio of S- and R-epimers of PMSO
are expected following reaction with HOCl and since MsrA is
specific for the S-form of PMSO.
The ability of TXNL6 to serve as a reducing system for MsrA-
repair of a-crystallin/sHSP was also evaluated using CNBr. Tricine-
SDS-PAGE gel analysis of CNBr-cleaved untreated a-crystallin/
sHSP (Figure 8, Lane 1) produced 6 peptide products, the original
parent aA-crystallin (19 kDa) and aB-crystallin (20 kDa) peptides
and four CNBr-cleavage products with molecular weights of
approximately 16 kDa, 12 kDa, 8 kDa and 4 kDa. These bands
are consistent with CNBr cleavage at met 138 of aA- and met 68 of
aB-crystallin, respectively. The two smaller predicted cleavage
products of approximately 4 kDa (aA-crystallin) and approximately
8k D a( aB-crystallin) were also detected. Met-oxidation of a-crystallin
(9.09 mM) with HOCl (0.9 mM for 15 min at room temperature;
100:1 molar ratio) led to loss of cleavage by CNBr indicating the
presence of oxidized met 68 of aB-crystallin and met 138 of aA-
crystallin resulting in the detection of only aA-crystallin and aB-
crystallin parent proteins (Figure 8, Lane 2). Incubation of the met-
oxidized a-crystallin (6.36 mM) with MsrA (100 nM for 2 h at 37uC)
and increasing amounts (10 mgo r2 0mg) of TXNL6 with TxrR/
NADPH as an MsrA reducing system repaired the oxidized mets as
evidenced by the detection of cleavage products missing in the
oxidized form (Figure 8, Lanes 4 and 5). As a control, DTT (15 mM)
also resulted in repair of oxidized a-crystallin/sHSP (Figure 8, Lane
3) as previously shown [27]. Based on the intensity of the bands in the
repaired samples (compare Figure 8, Lanes 1, 3 and 5) the repair of
met oxidized a-crystallin was more efficient with 20 mgo fT X N L 6
compared to 10 mg TXNL6 showing some concentration depen-
dence for TXNL6-mediated MsrA repair of a-crystallin/sHSP. The
TXNL6-mediated MsrA repair of a-crystallin/sHSP was less than
100% as estimated by band intensity. This is to be expected since, at
most, 50% of mets will be oxidized to form the S-form of PMSO that
MsrA specifically recognizes, and the reaction is unlikely to be 100%
efficient. Collectively, these studies show that TXNL6 can act as an
MsrA reducing systemfor repair of cytc and a-crystallin/sHSP that is
dependent on the level and reduced state of TXNL6.
Discussion
It is well accepted that increasing ROS levels during the aging
process can cause oxidative damage to cellular proteins whose
consequent loss of function contributes to age-onset degenerative
disease. To combat damage by ROS, the cell has evolved a diverse
range of defenses including specific protein repair systems that
restore function to oxidized proteins. Key to the action of these
repair proteins is the availability of specific reducing systems
required for their catalytic activity. Decreased levels and/or
availability of these reducing systems likely limits the activity of
oxidative protein repair systems leading to accumulation of
oxidized proteins and disease. Identification of those reducing
systems and elucidation of the mechanisms that govern their
expression and availability under oxidative conditions should
provide insight into the regulation and function of repair protein
and the etiology of oxidative diseases.
In the present report, we examined the expression of TXNL6 in
sub-populations of lens cells, its sub-cellular location in lens cells,
its induction under oxidative stress conditions, and its reducing
activity for the action of MsrA on two model lens proteins. The
results of this study are applicable to understanding the
requirements for MsrA function on a wide range of met oxidized
target proteins and disease states since methionine is one of the
most oxidizable protein amino acids [13] and PMSO accumula-
tion is associated with a broad range of age-related human
disorders associated with methionine oxidation including Alzhei-
mer’s disease, Parkinson’s disease, respiratory distress syndrome,
emphysema, and reperfusion injury [1][2][3][4][5][7][14][15].
Age-related cataract of the eye lens is an excellent model for
examining the role of protein oxidation in disease, and the aging eye is
Figure 5. TXNL6 mRNA and protein are induced by oxidative
stress exposure of human lens epithelial cells. A. Ethidium
bromide stained agarose gels showing TXNL6 and control GAPDH
transcript levels in 200 ng RNA isolated from HLE-B3 human lens
epithelial cells at 0, 30 min, 6 h and 16 h recovery following a 2 h
exposure to 200 mMH 2O2. B. Western blot showing TXNL6 protein
levels in 5 mg of total protein extract isolated from HLE-B3 lens
epithelial cells at 0, 6 h, 16 h and 24 h recovery following a 2 h
exposure to 200 mMH 2O2. The coomassie blue stained SDS-PAGE gel is
shown as a control for equal protein loading.
doi:10.1371/journal.pone.0015421.g005
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independent experiments) of cytochrome c (cyt c) mediated peroxidase activity. The graph shows mean values for an N of 3 6 SD. Cyt c oxidized (cyt
c ox) (incubated for 15 min with a 4:1 molar ratio of HOCl) is 100% peroxidase activity, all other activities are expressed as a percentage of the cyt c ox
activity. The untreated cyt c protein has 16% cyt c peroxidase activity compared to cyt c ox. Cyt c ox incubated with MsrA in the absence of a
reducing system has 91% activity of the oxidized. Treatment of the cyt c ox (291 mM) with MsrA (1.9 mM for 2 h at 37uC) and TXNL6 (1.39 mM) with
thioredoxin reductase (TxrR) and NADPH leads to a statistically significant (p,0.001) 48% decrease in peroxidase activity. Similarly treatment of cyt c
ox with MsrA and either Trx 1 or Trx 2 (both 1.39 mM) with TxrR/NADPH also significantly (p,0.001) decreased both peroxidase activities by 52% and
54% respectively. Incubation of cyt c ox with MsrA and TXNL6 in the absence of TxrR/NADPH resulted in just a 14% decrease in cyt c peroxidase
activity while incubation of cyt c ox with TXNL6 and TxrR/NADPH in the absence of MsrA resulted in 19% decrease in cyt c peroxidase activity. p
values were obtained using Tukey’s test following one-way ANOVA.
doi:10.1371/journal.pone.0015421.g006
Figure 7. MsrA repairs oxidized methionines in cytochrome c using TXNL6 as a reducing agent. Coomassie staining of a Tricine-SDS-
PAGE gel following CNBr cleavage of oxidized cyt c (5 mg). Lane 1 untreated cyt c cleaved with CNBr. Lane 2 Oxidized cyt c (0.2 mM oxidized with
0.8 mM HOCl; a 4:1 Molar ratio) cleaved with CNBr. Lane 3 Oxidized cyt c (291 mM) treated with MsrA (1.9 mM) and DTT (15 mM) for 2 h at 37uC and
cleaved with CNBr. Lane 4 Oxidized cyt c (291 mM) treated with MsrA (1.9 mM) and TXNL6 (10 mg; 1.39 mM) for 2 h at 37uC and cleaved with CNBr. RA -
reducing agent/system.
doi:10.1371/journal.pone.0015421.g007
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that defend against oxidative stress-associated diseases. The lens is a
simple structure consisting of only two cell types, it is directly exposed to
environmental UV-light, smoke, and other oxidizing agents. It lacks a
blood supply and as an encapsulated organ is isolated from the
immune system and other systemic influences. Importantly, the cells of
the lens and the proteins they contain are not turned over or renewed
and therefore must remain un-oxidized for the entire lifetime of an
individual for the lens to maintain its transparent function.
One key characteristic of cataract is increased PMSO
accumulation which can be repaired by MsrA. MsrA is critical
for eye lens function since it is required for oxidative stress
resistance in the lens [20–21] and prevention of cataract formation
[26]. MsrA can repair met oxidized lens proteins and is essential
for lens function [20–21][26–27]. Deletion of MsrA causes
cataract in oxidative stress-treated mice demonstrating its
importance in lens defense against oxidative stress [26]. MsrA
has demonstrated ability to protect lens cells [20–21] and has been
shown to repair lens proteins critical for lens function [26–27].
Despite the importance of MsrA for lens function, its required
reducing system in the lens is not known. Bacterial and yeast MsrA
can use bacterial and yeast thioredoxin as a reducing system [61],
while other studies suggested that mammalian MsrA may employ
reducing systems in addition to or other than Trx [37].
In the present report we provide evidence that in addition to
Trx 1 and Trx 2, TXNL6 could be a robust reducing system for
MsrA-mediated repair of met sulfoxide in the critical lens proteins
alpha-crystallin/sHSP and cyt c, that TXNL6 is expressed at high
levels in lens epithelial cells and fiber cells where it co-localizes
with MsrA, and importantly, that TXNL6 is induced under the
same oxidative conditions that result in oxidation of lens proteins,
apoptosis of lens cells, and other events leading to cataract
formation. We chose to examine TXNL6 as a potential reducing
system for the action of MsrA based on recent studies showing its
importance in maintaining the viability of retinal cells in mice [38–
39]. TXNL6 (RdCVF in mice) is expressed as two RNA splicing
variants called RdCVFL (long form) and RdCVF (Short form)
[38]. The short form of RdCVF lacks the thioredoxin fold and acts
as a trophic factor for the growth of cone photoreceptor cells in the
mouse retina [38]. Importantly, disruption of the RdCVF gene
leads to photoreceptor dysfunction and increased susceptibility to
oxidative stress [39], suggesting a role for RdCVFL in protection
against oxidative stress damage. This long form of RdCVF
contains both the CXXC domain and the thioredoxin fold making
it a likely candidate to act as potential reducing system for the
action of MsrA repair activity in the eye lens and other tissues.
Only the long form of TXNL6 (RdCVFL in mice) was examined
in the present study, since the short form lacks the thioredoxin fold
believed to be necessary for oxidoreductase activity [39].
In the present study human TXNL6 was expressed in all tissues
examined including lens, retina, stomach, kidney, heart, colon,
and spleen suggesting that it is ubiquitously expressed in human
tissue. In the eye lens, we detected higher TXNL6 levels in the
fiber cells relative to the epithelium (Figure 1 and 2). Since the lens
fiber cells have to last throughout the lifetime of the individual and
contain some of the oldest cells in the body, the presence of
TXNL6 in the lens fibers supports its potential role in MsrA repair
of met oxidized proteins since MsrA is also located in the lens
fibers [20] and oxidation of fiber cell protein is believed to be a
crucial initiator of cataract formation [16]. The low levels of
TXNL6 in the epithelium could indicate it is expressed only under
oxidative stress conditions in this lens sublocation. There is some
evidence that lens cells grown in culture at 20% oxygen are indeed
stressed relative to the lower oxygen conditions of the lens in vivo.
Expression of TXNL6 in the lens epithelium suggests that TXNL6
might act to facilitate MsrA action in the mitochondria as well as
the cytoplasm of lens epithelial cells where MsrA has previously
been localized [26]. Consistently, sub-cellular localization of
TXNL6 using western blot analysis and immunofluoresence
staining revealed that TXNL6 was located in both the cytoplasm
and the mitochondria of lens epithelial cells (Figure 3 and 4).
These results suggest multiple roles for TXNL6 in the eye lens
including epithelial metabolism and maintenance of fiber cells.
MsrA has been shown to be critical for lens mitochondrial
function [21] and TXNL6 may serve as a reducing system for MsrA
inthe mitochondriaoflensepithelial cellsbased initsco-localization
Figure 8. MsrA repairs oxidized methionines in a-crystallin using TXNL6 as a reducing agent. Coomassie staining of a Tricine-SDS-PAGE
gel following CNBr cleavage of oxidized a-crystallin (5 mg). Lane 1 untreated a-crystallin cleaved with CNBr. Lane 2 Oxidized a-crystallin (9.09 mM
oxidized with 909 mm HOCl; a 100:1 Molar ratio) cleaved with CNBr. Lane 3 Oxidized a-crystallin (6.4 mM) treated with MsrA (100 nM) and DTT
(15 mM) for 2 h at 37uC and cleaved with CNBr. Lane 4 Oxidized a-crystallin (6.4 mM) treated with MsrA (100 nM) and TXNL6 (10 mg; 1.39 mM) for 2 h
at 37uC and cleaved with CNBr. Lane 5 Oxidized a-crystallin (6.4 mM) treated with MsrA (100 nM) and TXNL6 (20 mg; 2.78 mM) for 2 h at 37uC and
cleaved with CNBr. RA - reducing agent/system.
doi:10.1371/journal.pone.0015421.g008
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exposure of lens cells to H2O2-induced oxidative stress (Figure 5)
with both the mRNA and protein levels of TXNL6 significantly
increasingover24 hfollowingexposureto200 mMH 2O2(Figure5).
Previous studies have shown that TXNL6 expression is associated
with upregulation of NFkB activity in response to photooxidation in
cone photoreceptor cells [62], suggesting that induction of TXNL6
may be a universal response to defend multiple tissues against acute
oxidative stress damage through its activation of MsrA and
potentially other defensive and repair proteins.
To examine whether TXNL6 can act as a reducing system for
MsrA, we evaluated its ability to act as a reducing system for the
specific MsrA-repair of met 80 sulfoxide of the lens epithelial protein
cyt c and the specific MsrA-repair of oxidized met 138 (aA-crystallin
subunit) and met 68 (aB-crystallin subunit) in the predominately lens
fiber protein a-crystallin/sHSP. Cyt c is critical for mitochondrial
respiration and oxidation at met 80 results in loss of its electron
transport function, increased peroxidase activity [26][58] and cyt c
mediated apoptosis [59]. Previous studies showed that MsrA could
repair cyt c oxidized at met 80 using DTT as a reducing system [26].
a-crystallin/sHSP is both a refractive and chaperone protein in the
lensrequired forthemaintenanceoflenstransparency[30].Previous
studiesshowedthat MsrAcould repaira-crystallin/sHSP oxidized at
mets 138 and 68 using DTT as a reducing system [27]. TXNL6 was
able to substitute for DTT in the MsrA repair of met 80 of cyt c and
mets 138, 68 of a-crystallin/sHSP (Figures 7 and 8) in vitro.
Interestingly, repair of cyt c by MsrA using TXNL6 as a reducing
agent also decreased cyt c peroxidase activity (Figure 6). In addition,
similar to the action of Trx 1 and Trx 2, the ability of TXNL6 to act
as a reducing system for MsrA relied on the availability of a reducing
enzyme, in this case TxrR. These results provide evidence that in
lenses exposed to oxidative stress, increased levels of TXNL6 act to
serve asanMsrAreducing systemforrepairofcytcand a-crystallin/
sHSP in the lens, the maintenance of mitochondrial electron
transport, the prevention of cyt c-mediated apoptosis and the
maintenanceof the chaperone activity of a-crystallin/sHSPrequired
for the prevention of cataract formation. Since TXNL6, Trx 1 and
Trx 2 are present in the lens and as shown here act on MsrA, it is
likely that they have different functions in the lens. Some of these
may be spatially restrictive while other functions may depend on
growth and environmental conditions. The induction of TXNL6
demonstrated inthepresentreport(Figure5)suggeststhatTXNL6is
the major reducing system for MsrA under oxidative stress
conditions and that Trx 2 in the mitochondria and Trx 1 may be
more important for MsrA action under non-stressed conditions.
In addition to acting on MsrA it is likely that TXNL6 also acts
on other Trx requiring enzymes including peroxiredoxins [63].
TXNL6 is one of a family of thioredoxin-like proteins. Of these,
TXNL1, TXNL5 and TXNL6 contain the thioredoxin CXXC
domain and therefore could also act on MsrA and as reducing
systems for other Trx dependent enzymes. The TXNL2 and
TXNL4 members of this family are mono-thiols potentially
harboring some regulatory function yet to be elucidated. Other
studies [64] have shown that TXNL2 in addition to TXNL6 is
present in the lens and we have detected expression of TXNL1 in
the lens (unpublished). Future work is needed to examine the
effectiveness of the TXNL6 reducing system for MsrA activation
relative to other members of the TXNL family, Trx 1 and/or Trx
2, which will likely depend on the cell type, sub-cellular expression
pattern, differentiation state, oxidation exposure and specific MsrA
target protein examined. Since, Trx 1, Trx 2 and TXNL6 depend
on TxrR and NADPH for their activities [63][65], understanding
the potential regulation and expression of TxrR in lens cells upon
aging and oxidative conditions is also likely to provide important
clues towards understanding the actions of TXNL6 and MsrA in
the lens and other tissues. In the lens NADPH is predominantly
made in the lens epithelium and possibly the cortical fibers which
both contain energy producing mitochondria. Thus, NADPH
would likely need transport or diffusion to the inner fibers
suggesting that analysis of NADPH levels would also provide
insight into the role of TXNL6 and other NADPH-dependent
reducing systems on the activities of MsrA.
Regardless of the outcomes of these future studies, the data
established in the present report show that TXNL6 is ubiquitously
expressed in eye lens and other human tissues. Strikingly, TXNL6
is induced upon oxidative stress conditions which suggests a
specific role for TXNL6 in defense of cells against oxidative stress.
We also demonstrate that TXNL6 is a novel reducing system for
MsrA repair of cellular proteins whose lost functions upon
methionine oxidation contribute to eye lens cataract formation.
These results provide a greater understanding of the requirements
of MsrA for many functions and disease states and likely extend a
role for TXNL6 in the function of other cellular protective and
repair systems. Finally, recent evidence suggests that the levels of
reducing systems are the limiting factors in the function of MsrA in
oxidative defense [66]. The results presented in this report
demonstrating oxidative induction of TXNL6 suggest it plays a
key role in MsrA function under oxidative stress conditions and
that control of its induction may be a limiting factor in the ability
of MsrA to defend against oxidative stress and disease.
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